Vardenafil Hydrochloride
Product Images NDC 73750-104

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 19 technical images submitted to the FDA as part of the official labeling for Vardenafil Hydrochloride (NDC 73750-104). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Qyk Brands Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Qyk Vardenafil Hydrochloride 102 10

Qyk Vardenafil Hydrochloride  102 10
Vardenafil Hydrochloride Tablets 2.5 mg label by QYK Brands LLC. The label includes NDC 73750-102-10, medication strength, and dispensing instructions. It states that each film-coated tablet contains Vardenafil hydrochloride equivalent to 2.5 mg of Vardenafil. The label also provides dosage directions, storage conditions, and distribution and manufacturing information from QYK Brands and Macleods Pharmaceuticals Ltd. The package contains 100 tablets.*
FDA Label Image

Qyk Vardenafil Hydrochloride 102 30

Qyk Vardenafil Hydrochloride 102 30
This drug information panel for Vardenafil Hydrochloride tablets highlights the active ingredient strength as 2.5 mg per film-coated tablet. It includes dosage instructions advising taking one tablet as needed, not exceeding once daily. Storage conditions specify 20° to 25°C with allowable excursions, along with distributor and manufacturer details. The panel notes a pharmacist's instruction to dispense the patient information leaflet.*
FDA Label Image

Qyk Vardenafil Hydrochloride 103 10

Qyk Vardenafil Hydrochloride 103 10
Label for Vardenafil Hydrochloride Tablets 5 mg by QYK BRANDS LLC. The label states each tablet contains vardenafil hydrochloride equivalent to 5 mg vardenafil. It indicates a package size of 100 tablets, storage instructions, and distributor and manufacturer information, including Macleods Pharmaceuticals Ltd., India.*
FDA Label Image

Qyk Vardenafil Hydrochloride 103 30

Qyk Vardenafil Hydrochloride 103 30
Label for Vardenafil Hydrochloride Tablets 5 mg by QYK Brands LLC. The label states the NDC 73750-103-30 and package count of 30 tablets. It includes storage instructions, dosage guidance to take one tablet as needed no more than once per day, and identifies the manufacturer as Macleods Pharmaceuticals Ltd., India.*
FDA Label Image

Qyk Vardenafil Hydrochloride 104 10

Qyk Vardenafil Hydrochloride 104 10
Label for Vardenafil Hydrochloride Tablets 10 mg by QYK Brands LLC. The label includes NDC 73750-104-10 and indicates a package of 100 tablets. It provides storage instructions, usual dosage recommendations, distributor and manufacturer information, and a barcode area. The label instructs pharmacists to dispense the accompanying patient information leaflet.*
FDA Label Image

Qyk Vardenafil Hydrochloride 104 11

Qyk Vardenafil Hydrochloride 104 11
Vardenafil Hydrochloride Tablets 10 mg label from QYK Brands LLC. The label includes NDC 73750-104-11 and states the package contains 100 tablets (10 x 10 unit dose). It also notes dosage details, storage temperature, distributor QYK Brands in Garden Grove CA, and manufacturer Macleods Pharmaceuticals Ltd., India.*
FDA Label Image

Qyk Vardenafil Hydrochloride 104 30

Qyk Vardenafil Hydrochloride 104 30
Drug information panel for Vardenafil Hydrochloride Tablets 10 mg, showing the NDC 73750-104-30. It includes dosage instructions, storage conditions, and manufacturer details. The label notes the medication is prescription only and comes as a 30-tablet supply, distributed by QYK Brands LLC and manufactured by Macleods Pharmaceuticals Ltd., India.*
FDA Label Image

Qyk Vardenafil Hydrochloride 105 10

Qyk Vardenafil Hydrochloride 105 10
Vardenafil Hydrochloride Tablets, 20 mg, label by QYK BRANDS LLC. The label includes NDC 73750-105-10 and states the tablets are film-coated containing vardenafil hydrochloride equivalent to 20 mg vardenafil. Directions mention usual dosage and storage conditions. Package contains 100 tablets and is marked Rx only. Distributed by QYK Brands, made by Macleods Pharmaceuticals Ltd., India.*
FDA Label Image

Qyk Vardenafil Hydrochloride 105 11

Qyk Vardenafil Hydrochloride 105 11
Label for Vardenafil Hydrochloride Tablets 20 mg by QYK BRANDS LLC. The label includes dosage strength, NDC number 73750-105-11, dispensing instructions for pharmacists, storage temperature guidance, and distributor and manufacturer information. Package size is 100 tablets (10 x 10 unit dose).*
FDA Label Image

Qyk Vardenafil Hydrochloride 105 30

Qyk Vardenafil Hydrochloride 105 30
Label for Vardenafil Hydrochloride Tablets 20 mg by QYK Brands LLC. The label displays the NDC 73750-105-30, dosage strength of 20 mg, and quantity of 30 tablets. Key storage instructions and distribution details are included, along with a pharmacist advisory to provide patient information leaflets.*
FDA Label Image

Vardenafil-fig-5 (Vardenafil Fig 5)

Vardenafil-fig-5 (Vardenafil Fig 5)
A line graph depicting mean change in mmHg over time (hours) for placebo and Vardenafil at 5 mg and 10 mg doses. Four lines represent placebo in two stages and Vardenafil 5 mg and 10 mg, showing variations in mean change from 0 to 6 hours.*
FDA Label Image

Vardenafil-fig-6 (Vardenafil Fig 6)

Vardenafil-fig-6 (Vardenafil Fig 6)
Line graph titled Terazosin showing mean change in mmHg on the y-axis versus time in hours on the x-axis. It compares blood pressure changes for placebo and vardenafil at 10 mg and 20 mg doses under 6-hour separation and simultaneous administration conditions over a 6-hour period.*
FDA Label Image

Vardenafil-fig-7 (Vardenafil Fig 7)

Vardenafil-fig-7 (Vardenafil Fig 7)
A line graph titled "TAMSULOSIN" depicting mean change in mmHg on the y-axis and time in hours on the x-axis. It compares placebo, 10 mg Vardenafil, and 20 mg Vardenafil under two conditions: 6-hour separation and simultaneous administration. Different markers represent each group, showing changes over a 6-hour period.*
FDA Label Image

Vardenafil-fig-8 (Vardenafil Fig 8)

Vardenafil-fig-8 (Vardenafil Fig 8)
A line graph showing plasma concentration of vardenafil hydrochloride (µg/L) over time (hours). The plotted data points with error bars illustrate the decline in plasma concentration from an initial peak around 1-2 hours to near zero by 24 hours.*
FDA Label Image

Vardenafil-fig1 (Vardenafil Fig1)

Vardenafil-fig1 (Vardenafil Fig1)
A figure with three line graphs showing mean maximal change in Systolic BP, Diastolic BP, and Heart Rate over different timings of Vardenafil treatment pre-NTG (24h, 8h, 4h, 1h). The y-axes display changes in mmHg for blood pressures and bpm for heart rate, with error bars included for variability.*
FDA Label Image

Vardenafil-fig2 (Vardenafil Fig2)

Vardenafil-fig2 (Vardenafil Fig2)
A line graph depicting the mean change in mmHg over time (0 to 6 hours) for Vardenafil hydrochloride 5 mg and placebo. The graph compares simultaneous and 6-hour separation dosing for both treatments, showing different trends in blood pressure changes indicated by distinct markers and line styles.*
FDA Label Image

Vardenafil-fig3 (Vardenafil Fig3)

Vardenafil-fig3 (Vardenafil Fig3)
Line graph showing mean change in mmHg over time (0 to 6 hours) comparing placebo and Vardenafil 5 mg under simultaneous and 6-hour separation conditions. The graph tracks blood pressure changes with different treatments and timing, illustrating comparative trends for placebo and Vardenafil.*
FDA Label Image

Vardenafil-fig4 (Vardenafil Fig4)

Vardenafil-fig4 (Vardenafil Fig4)
A line graph showing mean change in mmHg over time (hours) comparing placebo and Vardenafil at 10 mg and 20 mg doses. The graph includes data for two stages of placebo (circles and triangles) and corresponding Vardenafil dosages (solid circles and triangles), depicting blood pressure changes over a 6-hour period.*
FDA Label Image

Vardenafil-str (Vardenafil Str)

Vardenafil-str (Vardenafil Str)
Chemical structure diagram of Vardenafil Hydrochloride, showing the molecular arrangement including rings, atoms, and bonds typical of the compound's hydrochloride hydrate form.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.